SUMMARY Introduction. Meningiomas are common primary tumors of brain meninges. These neoplasms develop from arachnoid cap cells and are multiple in 1 -10% cases. Occasionally, significantly higher multiplicity rates have been reported, at least partially due to the increased application of computed tomography and magnetic resonance imaging in the diagnostics of intracranial pathologies. Meningiomas generally express progesterone receptors, but only few studies have focused on sex hormone receptor differences between solitary and multiple meningiomas. Similarly, there is limited information on cell proliferation and adhesion factors in solitary and multiple meningiomas. Aim of the study. Was to evaluate the immunohistochemical differences in sex hormone receptor expression, cell proliferation and adhesion within solitary and multiple meningiomas. Material and methods. In a retrospective study, 11 consecutive multiple meningiomas and 20 grade-matched solitary meningiomas were assessed by immunohistochemistry (IHC) to detect estrogen receptors (ER), progesterone receptors (PR), Ki-67 and neural cell adhesion molecule (NCAM). IHC was followed by quantitative microscopic evaluation. Descriptive and inferential statistics was applied including confidence interval (CI) analysis, Mann-Whitney U test and Spearmen correlation by IBM SPSS Statistics 22.0 software; p values less than 0.05 were regarded as statistically significant. Results. Although PR were found in all samples, the mean expression was significantly lower in multiple meningiomas (p = 0.03): 30.0% (95% CI: 10.4 -49.8) versus 70.6% (95% CI: 56.6 -84.7) in solitary meningiomas. ER were invariably absent in both groups. The proliferation index did not differ in solitary and multiple tumors. There was a trend (p = 0.07) to higher mean expression of NCAM in multiple meningiomas than in control group: 48.3% (95% CI: 25.8 -70.8) versus 24.6% (95% CI: 13.2 -36.0), respectively. The multiple meningiomas showed diverse histological types and immunophenotypes in up to 33.3% patients. Conclusions. Multiple meningiomas are characterized by significant down-regulation of PR and up-regulation of NCAM. The last finding can indicate neural differentiation and/ or peculiarities of cell adhesion and signaling that facilitate multifocal proliferation. Diverse histological types as well as PR and NCAM expression in separate meningiomas within same patient indicate independent multicentric origin.
INTRODUCTION
Meningiomas are common primary tumors of brain meninges. In general, meningiomas comprise 36.1% of all primary tumors found in the central nervous system (CNS) and are the predominant primary CNS tumors after the age of 35 years (18) . These neoplasms develop from arachnoid cap cells. Meningiomas are mostly benign corresponding to World Health Organization (WHO) grade I (17) . The rate of multiplicity is reported to range between 1 -10% (7; 15) and is rising with the increased application of computed tomography and/ or magnetic resonance imaging (15) . Occasionally, estimates as high as 49% are published questioning if solitary meningiomas exist at all. However, regional multiplicity has been included in these data (4) . The prognosis of multiple meningiomas does not differ from solitary meningiomas (11; 15) . Although it is well known, that meningiomas express sex hormone receptors, only few studies have focused on estrogen receptor (ER) and progesterone receptor (PR) expression differences between solitary and multiple meningiomas. Neural cell adhesion molecule (NCAM) is a cell surface glycoprotein that exists in different isoforms and acts through several pathways, providing multiple functions (12) . Some authors have described impact of multiple if several tumors have been simultaneously resected from different locations or if multifocal growth was evident radiologically in clearly separated spatial locations. Tumor recurrence in the site of previous operation was not considered as an evidence of multifocality. After the multiple meningiomas have been identified, grade-, age-and gender-matched control group consisting of 20 solitary meningiomas was created for the immunohistochemical part of the study. The meningioma samples were tested for Ki-67 antigen, ER, PR and NCAM expression. Immunohistochemical visualization was applied for this purpose, using heatinduced antigen retrieval in basic (pH 9.0) buffer. The characteristics of primary antibodies are listed in Table 1 . The bound antibodies were detected by polymeric visualization system EnVision. All reagents for the immunohistochemistry were provided by Dako, Glostrup, Denmark. Positive and negative controls were performed and reacted appropriately. According to manufacturer's instructions, the following positive controls were employed: normal endometrium for estrogen and progesterone receptors and Schwann cells within neural fibers for NCAM. Normal endothelium was used as the internal negative control for NCAM, ER and PR. Tonsillar tissue was applied to control Ki-67. The proliferation index by Ki-67 was assessed by counting positively stained nuclei within 100 neoplastic cells in a high-power resolution (HPR), using magnification 400x. The "hotspot" areas of the highest antigen expression were investigated. PR and ER were evaluated by counting positive nuclei in 3 "hotspot" HPR fields. NCAM expression was measured by the relative amount (%) of positive cells in the entire sample on low-power magnification (100x). Cells were considered positive for NCAM if an unequivocal positive reaction was observed in the cell membrane. All immunohistochemical data were expressed quantitatively as the relative number of positive neoplastic cells (%). Data were analyzed using IBM SPSS Statistics 22.0 software. Descriptive statistical analysis was performed including calculation of 95% confidence interval (CI). The normality was assessed by Shapiro-Wilk test. Differences between groups were determined by the non-parametric Mann-Whitney U test. The nonparametric Spearman's rank correlation coefficient was used to identify the statistical dependence between two variables. The differences were considered statistically significant if p < 0.05.
RESULTS
The archive search for all consecutive surgically treated patients affected by meningiomas yielded 378 cases. Multiple meningiomas were found in 7 (1.9%; 95% CI: 0.8 -3.9) patients, including six females and one male. The mean patient's age at the time of operation was 55.7 years (95% CI: 43.1 -68.3). All tumors were grade I according to WHO classification. Three patients had more than one meningioma removed. Among them one had diverse tumors of fibrous and transitional histological types. The remaining two patients had transitional meningiomas. Three patients with single surgically removed meningioma had transitional meningioma, one patient -fibrous meningioma ( Figure  1 ). 
DISCUSSION

Meningiomas were first described by Cushing and
Eisenhardt as early as on 1938. Already then, multiple meningiomas were recognized and defined as spatially separated tumors (15) . The incidence of multiple meningiomas was estimated as 1 -2% in the early reports while higher incidence has been observed with the increasing application of the computed tomography of brain. Magnetic resonance imaging yielded even higher numbers of multiple meningiomas due to the possibility to detect small tumors and meningiomas in the posterior fossa, skull base and vertex (15) . In our study, we defined multiple meningiomas as spatially separated lesions, and the frequency of multifocality in our study is in line with the early reports (7). Thus, multiple meningiomas were rare in our study as only 11 cases have been enrolled despite the significant number of consecutive surgically treated meningiomas. Although the small sample size may affect statistical analysis, we succeeded to subject the entire scope of identified multiple meningiomas to the immunohistochemical study.
The indications for surgical treatment in multiple meningiomas are not different from those in solitary tumors: meningioma should be removed if it is symptomatic, larger than 3 cm or expanding. Multiplicity alone is not an indication for complete removal of all tumors (15) . So far only Huang et al. (14) have reported on the differences of PR expression in large groups of multiple and solitary meningiomas, including 45 multiple and 31 solitary tumors. They revealed PR expression in all meningiomas, with higher levels in multiple tumors. The authors explained their results by a hypothesis suggesting possible PR role in facilitating desquamation and dissemination of tumor cells. However, the expression of PR has been described as a favorable prognostic factor in most studies. Lack of PRs and/ or presence of ERs in meningioma are associated with higher possibility of genetic mutations, tumor recurrence and rapid progression, on the contrast higher grade meningiomas lack PRs (13; 20; 22; 23). Here we present our data evidencing significantly lower PR expression in multiple meningiomas. Appropriately matched control group, as was designed in our study, could be necessary to find and justify the true differences between solitary and multiple tumors. An expression of ERs in meningiomas is rare and usually is associated with higher grade meningiomas. The scarcity of its expression in grade I tumors in this study concurs the reports of other authors (13; 20 (8) . This is the first study assessing NCAM in multiple meningiomas. The results show a trend to higher expression of NCAM in MMs; this might be one of mechanisms that facilitate cell dissemination. However, diverse NCAM expression as well as different PR expression and histological types in separate meningiomas within same patient indicate multicentric origin of multiple meningiomas.
CONCLUSIONS
Solitary and multiple meningiomas are biologically different. Multiple meningiomas are characterized by significant down-regulation of PR expression -marker that has been previously associated with clinical course. The lack of PR can lead to lower efficacy of antiprogesterone therapy in a fraction of patients affected by multiple meningiomas. The up-regulation of NCAM in multiple meningiomas can indicate neural differentiation and/ or peculiarities of cell adhesion and signaling that facilitate proliferation in multiple foci. Diverse histological types as well as PR and NCAM expression in separate meningiomas within same patient indicate multicentric origin.
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